Subscribe To
Hepion pharmaceuticals schedules conference call to review topline results from phase 2 ‘altitude-nash' liver function trial of rencofilstat
EDISON, N.J., May 19, 2023 (GLOBE NEWSWIRE) -- Hepion pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical s...
May 19, 2023, 4:05 pm
Pbe offers exposure to surging catalent stock
Shares of Catalent (CTLT) are surging on Friday after the contract pharmaceuticals manufacturer provi...
May 19, 2023, 2:41 pm
Alimera (alim) up on deal with eyepoint for u.s. rights to yutiq
Alimera Sciences ALIM announced acquiring additional U.S. commercialization rights for 0.18 mg dose strength of Yutiq from EyePoint ...
May 19, 2023, 1:46 pm
Sab biotherapeutics presents virtual 2023 r&d day portfolio update: breakthrough immunotherapy innovations
SIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biop...
May 19, 2023, 12:30 pm
Ultragenyx to present at the 2023 barclays – gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Ultragenyx pharmaceutical Inc. (NASDAQ: RARE), a bio<...
May 19, 2023, 12:30 pm
Steris (ste) continues to face dull dental sales, margin woes
STERIS (STE) competes for pharmaceutical, research and industrial customers against several large compa...
May 19, 2023, 12:14 pm
Reviva pharmaceuticals joins webull corporate communications service platform
CUPERTINO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Reviva pharmaceuticals Holdings, Inc. (NASDAQ: RVP...
May 19, 2023, 10:30 am
Ultragenyx to present at the 2023 barclays - gene editing & gene therapy summit
NOVATO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Ultragenyx pharmaceutical Inc. (NASDAQ: RARE), a bio...
May 19, 2023, 8:30 am
Ambrx appoints stephen glover as chairman of its board of directors
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Stephen Glover has joined the Company...
May 18, 2023, 8:05 pm
Taro to release full year results on may 23, 2023
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro pharmaceutical Industries Ltd. (NYSE: TARO) announced today that...
May 18, 2023, 4:46 pm
Regeneron announces investor conference presentations
TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) -- Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) will w...
May 18, 2023, 4:01 pm
Regeneron applauds supreme court’s unanimous opinion striking down amgen’s pcsk9 patent claims and supporting scientific innovation
Decision ends nearly decade-long patent dispute related to Regeneron-invented Praluent® (alirocumab) TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) �...
May 18, 2023, 3:45 pm
Reasons to retain cardinal health (cah) in your portfolio
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversifie...
May 18, 2023, 1:02 pm
Mink’s novel fap-car-inkt presented at asgct
FAP-CAR-IL-15 iNKT cell therapy (MiNK-215) promotes curative responses driving tumor elimination and immune infiltration in NSCLC models IND enabling ...
May 18, 2023, 12:30 pm
Beyondspring and leading cancer center to present poster at 2023 asco annual meeting
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage bio
May 18, 2023, 12:30 pm
Why teva pharmaceutical stock is jumping today
Teva announced a new growth strategy. This news sparked an upgrade of the pharma stock by one analyst....
May 18, 2023, 11:59 am
Why is alimera sciences (alim) stock up 21% today?
Alimera Sciences (NASDAQ: ALIM ) stock is taking off on Thursday after signing a major deal with EyePoint phar...
May 18, 2023, 10:52 am
Why is teva pharmaceuticals (teva) stock up today?
Teva pharmaceuticals (NYSE: TEVA ) stock is climbing higher on Thursday after the ...
May 18, 2023, 10:37 am
Low migration inks market to top us$ 2.8 billion by 2033 as government bodies put forward stringent food safety norms in action | future market insights, inc.
During the forecast period from 2023 to 2033, the low migration inks industry in the United States is projected to experience significant growth, with...
May 18, 2023, 10:30 am
Reviva pharmaceuticals to present at upcoming investor conferences in may 2023
CUPERTINO, Calif., May 18, 2023 (GLOBE NEWSWIRE) — Reviva pharmaceuticals Holdings, Inc. (NASDAQ: RVP...
May 18, 2023, 10:30 am